Neonatal Jaundice: Lines of Management in Children’s Hospital at Kirkuk city, Iraq
DOI:
https://doi.org/10.62480/tjms.2022.vol9.pp1-7Keywords:
Jaundice, TSB, Term, PretermAbstract
Background: Jaundice is observed in first week of life in 60% of term & 80% of preterm infants, it is usually benign, but untreated, severe indirect hyperbilirubinemia is potentially toxic to nervous system of neonate.
Aim of the study: Identify the factors affecting the lines of management of neonatal jaundice.
Patients &Methods: this cross sectional study was carried out at neonatal intensive care unit (NICU) of Children's Hospital in the City of Kirkuk, Iraq; from May 2020 to November 2020.Data were collected from228 admission records. The age of patients were 1 day to 28 days.
Results: from 228 neonate ,166(72%) had neonatal jaundice,128(77.1%)were term ,38(22.8%) were preterm, the factors studied were (level of total serum bilirubin TSB ,term ,preterm ,age of neonate ,& weight) with lines of management used in NICU (phototherapy ,antibiotics ,combined phototherapy with antibiotics ,& exchange transfusion ).There was a significant association between these factors & the lines of management applied .
Conclusion: level of serum bilirubin is the most important factor in the management and the study showed a significant association between level of serum bilirubin and the other factors studied with the lines of management
Recommendation: Educating families about early recognition of jaundice &seeking medical advice is important to avoid invasive procedures like exchange transfusion and it is be better to start phototherapy earlier &at lower TSB level in low birth weight babies
References
Stoll B J.Kliegman RM . Jaundice and hyperbilirubinemia in the newborn. In: Beherman RE,Kliegman RM ,Jensen HB ,eds.Nelson Textbook of Pediatrics .17th ed. WB Saunders Co :Philadelphia PA:2004:91:592-599.
Saeidi R. Heydarian F.,Fakehi V.,Role of intravenous extra fluid therapy in icteric neonates receiving phototherapy .Saudi Med J,2009;30:1176-1178.
Maisels MJ. Jaundice in the newborn .Pediatrics in Review.2006; 27:443-455.
Weinberg R P.Gastroenterology. I.Bilirubin physiology In:Roberton NRC.ed.Textbook of neonatology.London: Churchill Livingstone; 1986:383-393.
Amin SB. ,Lamola AA.,Newborn jaundice and bilirubin binding capacity in neonate, Semin Perinatol .2011;35(3):134-140.
Dennery PA.,Seidman DS., Stevenson DK. Neonatal hyper bilirubinemia . N Engl Med 2001:344:581-590 .
Maisels MJ.,Baltz RD ,Bhutani V,et al.Management of hyperbilirubinemia in the newborn infant 35or more weeks of gestation. Pediatrics.2004;114:297-316.
Watchko JF. hyperbilirubinemia and bilirubin toxicity in the late preterm infant. Clin Perinatol .2006 ;33(4):839-852.
Wang X.,RoyChowdhury J.,RoyChowdhury N.Bilirubin metabolism:Applied physiology.Curr Pediatr .2006;16:70-74.
XiangT.,Qu Y.,Cambiers S.,et al. The side effects of phototherapy for neonatal jaundice:what do we know?what should we do?.Eur J Pediatr .2011; 1:338-339.
Watchko JF. Neonatal hyperbilirubinemia –what are the risks? N Engl Med. 2006;354:1947-1949.
MacDongh AF., Palmer LA., Lightner DA. Phototherapy for neonatal jaundice. J Am Chem Soc.1982;104:6867.
Ennever JF.Blue light,green light,white light ,more light:treatment of neonatal jaundice.Clin Perinatol ,1990;17:467-481.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
